Xiao Jiang Selected Research

Squamous Cell Carcinoma of Head and Neck

1/2022	Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
1/2021	Long non‑coding RNA MIR4713HG aggravates malignant behaviors in oral tongue squamous cell carcinoma via binding with microRNA let‑7c‑5p.
1/2021	circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
1/2020	CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.
3/2016	Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
1/2016	CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Jiang Research Topics

Disease

43	Neoplasms (Cancer) 04/2024 - 12/2012
16	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2014
12	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2015
11	Carcinogenesis 04/2024 - 04/2010
9	Lung Neoplasms (Lung Cancer) 02/2023 - 12/2012
8	Necrosis 04/2021 - 07/2013
6	Infections 01/2023 - 08/2010
6	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2016
5	Inflammation (Inflammations) 03/2024 - 01/2019
5	Virus Diseases (Viral Diseases) 09/2018 - 12/2014
4	Insulin Resistance 01/2024 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 10/2021
4	Hypoxia (Hypoxemia) 07/2023 - 09/2014
4	COVID-19 01/2023 - 01/2020
4	Hypertension (High Blood Pressure) 01/2021 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2015
3	Pneumonia (Pneumonitis) 01/2021 - 04/2020
3	Bacterial Infections (Bacterial Infection) 09/2020 - 11/2015
3	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 04/2010
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 10/2022
2	Ischemia 10/2023 - 01/2017
2	Ulcer 10/2023 - 01/2023
2	Wounds and Injuries (Trauma) 10/2023 - 05/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 08/2023 - 01/2021
2	Clostridium Infections 01/2023 - 07/2022
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2023 - 01/2021
2	Brain Diseases (Brain Disorder) 10/2022 - 01/2022
2	Fibrosis (Cirrhosis) 04/2022 - 02/2019
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2021
2	Pain (Aches) 01/2021 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 02/2020 - 01/2019
2	Spontaneous Abortion (Miscarriage) 07/2019 - 01/2018
2	Congenital Abnormalities (Deformity) 01/2019 - 05/2018
2	Myocardial Infarction 01/2019 - 07/2014
2	Essential Hypertension 12/2007 - 05/2007
1	Glioma (Gliomas) 04/2024
1	Stomach Neoplasms (Stomach Cancer) 04/2024
1	Atopic Dermatitis (Atopic Eczema) 03/2024
1	Depressive Disorder (Melancholia) 03/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Cognitive Dysfunction 01/2024

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2015
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2015
10	Messenger RNA (mRNA)IBA 02/2023 - 12/2012
8	LipopolysaccharidesIBA 09/2020 - 12/2014
6	CateninsIBA 10/2023 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
6	Poly I-CIBA 09/2020 - 12/2014
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2023 - 09/2015
5	Transcription Factors (Transcription Factor)IBA 10/2023 - 03/2015
5	CytokinesIBA 01/2023 - 08/2010
5	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2018
5	Long Noncoding RNAIBA 06/2022 - 03/2020
5	hypericinIBA 04/2021 - 07/2013
4	Indicators and Reagents (Reagents)IBA 01/2021 - 07/2014
4	Small Interfering RNA (siRNA)IBA 07/2020 - 01/2017
3	Peptides (Polypeptides)IBA 07/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2018
3	Competitive Endogenous RNAIBA 06/2022 - 01/2021
3	LigandsIBA 01/2022 - 03/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
3	ChemokinesIBA 01/2021 - 03/2016
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 05/2007
3	Estrogen ReceptorsIBA 01/2020 - 03/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 06/2015
2	Gemcitabine FDA Link 01/2024 - 01/2019
2	Insulin (Novolin)FDA Link 01/2024 - 01/2020
2	CollagenIBA 10/2023 - 04/2022
2	AlkaloidsIBA 07/2023 - 01/2014
2	LuciferasesIBA 02/2023 - 11/2017
2	Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2021
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2021
2	Histones (Histone)IBA 10/2021 - 02/2019
2	Hormones (Hormone)IBA 06/2021 - 01/2018
2	Cytokine Receptors (Cytokine Receptor)IBA 06/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 11/2020
2	Lysine (L-Lysine)FDA Link 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	S100A12 ProteinIBA 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
2	CC ChemokinesIBA 07/2020 - 03/2016
2	SolventsIBA 01/2020 - 05/2014
2	AerosolsIBA 09/2017 - 04/2017
2	Decitabine FDA Link 04/2015 - 12/2012
1	Immunoglobulin E (IgE)IBA 03/2024
1	Interleukin-13IBA 03/2024
1	DinitrofluorobenzeneIBA 03/2024
1	Interleukin-4 (Interleukin 4)IBA 03/2024
1	OligosaccharidesIBA 03/2024
1	BMS201038IBA 01/2024
1	Insulin-Like PeptidesIBA 01/2024
1	CreatinineIBA 01/2024
1	Cancer VaccinesIBA 12/2023

Therapy/Procedure

13	Therapeutics 04/2024 - 12/2012
6	Radiotherapy 04/2024 - 04/2021
2	Aftercare (After-Treatment) 09/2023 - 12/2012
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2019